Cogent Biosciences, Inc. announced the appointment of Todd E. Shegog to its Board of Directors. Todd currently serves as the Chief Financial Officer for Forma Therapeutics and has more than 25 years of financial, operations, corporate strategy, and compliance expertise in the biotechnology and pharmaceutical industries. Prior to Forma Therapeutics, Todd most recently served as Chief Financial Officer for Synlogic, where he directed the company's financial strategy and management as well as facilities and information systems.